-
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages
ソース: Buzz FX / 08 2 2025 04:06:10 America/New_York
Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Shares of Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) have received an
Read more...